Target (CBDY) Operating Income (2015 - 2026)
Target (CBDY) reported Operating Income of -$309887.0 for Q1 2026, down 301.78% year-over-year from $153574.0 in Q1 2025, and down 20.68% quarter-over-quarter from -$256774.0 in Q4 2025.
Target (CBDY) Operating Income (2015 - 2026) Analysis & Trends
Target (CBDY) has 12 years of Operating Income data on file, last reported at -$309887.0 in Q1 2026.
- Operating Income for Q1 2026 came in at -$309887.0, down 301.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$685186.0 (down 159.11% YoY), and the FY2025 annual result was -$221725.0, down 119.86% from the prior year.
- Operating Income fell to -$309887.0 in Q1 2026 per CBDY's latest filing, from -$256774.0 in the prior quarter.
- Over five years, Operating Income peaked at $901156.0 in Q2 2024 and troughed at -$309887.0 in Q1 2026.
- A 5-year average of $57293.5 and a median of $92211.5 in 2022 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2024: Operating Income sank 350.78% in 2023, then jumped 913.87% in 2024.
- A 5-year view of Operating Income shows it stood at $217006.2 in 2022, then sank by 64.67% to $76661.0 in 2023, then surged by 346.36% to $342187.0 in 2024, then tumbled by 175.04% to -$256774.0 in 2025, then retreated by 20.68% to -$309887.0 in 2026.
- Business Quant data shows CBDY's Operating Income at -$309887.0 in Q1 2026, -$256774.0 in Q4 2025, and -$255652.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -78.32 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Target | - | - | 191,787.00 | -309,887.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -309,887.00 |
| Dec 31, 2025 | -256,774.00 |
| Sep 30, 2025 | -255,652.00 |
| Jun 30, 2025 | 137,127.00 |
| Mar 31, 2025 | 153,574.00 |
| Dec 31, 2024 | 342,187.00 |
| Sep 30, 2024 | -237,781.00 |
| Jun 30, 2024 | 901,156.00 |
| Mar 31, 2024 | 111,154.00 |
| Dec 31, 2023 | 76,661.00 |
| Sep 30, 2023 | -56,503.00 |
| Jun 30, 2023 | -110,725.00 |
| Mar 31, 2023 | -231,251.00 |
| Dec 31, 2022 | 217,006.16 |
| Sep 30, 2022 | 191,868.82 |
| Jun 30, 2022 | 209,616.61 |
| Mar 31, 2022 | 92,211.52 |
| Dec 31, 2021 | -392,386.41 |
| Sep 30, 2021 | -66,325.23 |
| Jun 30, 2021 | -372,782.00 |